Half of kidney cancer patients initially misdiagnosed
October 30, 2018Manufacturing and Production Cancer, Kidney cancer, NHS, UK, diagnosis
Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. Despite being the …
UK MPs call for greater action on clinical transparency and trial reporting
October 30, 2018Manufacturing and Production, Research and Development UK, c linical transparency, clinical trials, pharma, transparency
The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …
GSK announces results of three year trial into long-lasting HIV injection
October 30, 2018Manufacturing and Production GSK, HIV, drugs, injection, medication
GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …
NHS to receive additional £20.5 billion each year from 2018 Budget
October 30, 2018Manufacturing and Production Budget, Conservatives, Labour, NHS, mental health, politics
The NHS will receive an additional £20.5 billion a year until 2023-24, according to the Budget released yesterday. The confirmation …
Effective preventative therapies for type 2 diabetes are underused, new research argues
October 30, 2018Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes
New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …
Not so crystal clear: The EU’s clinical reporting problem
October 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency
With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …
US court overturns J&J’s Zytiga patent in combination with prednisone
October 29, 2018Sales and Marketing J&J, JJ, Johnson and Johnson, Zytiga, court, generic, prednisone
A court in New Jersey has invalidated Johnson & Johnson’s patent on the prostate cancer drug Zytiga when used in …
Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration
October 29, 2018Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma
Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …
Vaccine coverage falls by 6.2% since last year
October 29, 2018Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines
Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …
Pfizer and Novartis partner up to develop combo therapies for NASH
October 29, 2018Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma
Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …
HHS Secretary Alex Azar responds to pharma sector’s criticism over Medicare pricing plan
October 29, 2018Sales and Marketing
US Health and Human Services (HHS) Secretary Alex Azar responded to industry criticism on Friday after big pharma warned that …
President Trump unveils new plans to bring US drug prices in line with the rest of the world
October 26, 2018Medical Communications, Sales and Marketing Drug pricing, Trump, US, pharma
Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …
Top Ten most popular articles on Pharmafile.com this week!
October 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10
Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …
India declares Sterling Biotech owners ‘Economic Fugitives’
October 26, 2018Medical Communications India, Modi, Sandesara, Sterling Biotech, corruption
India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new powers …
NICE issues draft guidance rejecting Abbvie’s Venclyxto in chronic lymphocytic leukaemia
October 26, 2018Medical Communications, Sales and Marketing AbbVie, NHS, NICE, leukaemia, pharma, venetoclax
It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …
Magic mushroom ingredient psilocybin gains breakthrough therapy designation
October 26, 2018Medical Communications Breakthrough Therapy Designation, Compass, FDA, Magic mushrooms, psylicobin
The US Food and Drug Administration (FDA) has given psilocybin – the psychoactive ingredient in ‘magic mushrooms’ – breakthrough therapy …
GSK opens £54m API plant in Montrose, Scotland
October 25, 2018Manufacturing and Production API, GSK, Scotland, manufacturing, montrose
British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines. The new facility …
Amgen slashes price of cholesterol drug Repatha by 60%
October 25, 2018Sales and Marketing Repatha, cholestrol, drug, medicine, pricing
American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%. The …
FDA generics approvals up 90% compared to 2014
October 25, 2018Sales and Marketing FDA, Trump, generics, pharma
Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic …
Measles outbreak threatens to decimate isolated Amazonian tribe in Venezuela and Brazil
October 25, 2018Medical Communications Brazil, Venezuela, measles, tribe, vaccines, yanomami
An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
